SAB - Army Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

SAB and DoD advance therapeutic drug candidate for Covid-19

SAB Biotherapeutics has won an expanded scope on its Rapid Response contract for its new therapeutic drug candidate to treat Covid-19 pandemic. Credit: SAB Biotherapeutics.